Pfizer Inc v. Sun Pharma Global Fze

Court

District Court, D. New Jersey (D.N.J.)
Official Court Website →

Assigned judge

Renee Marie Bumb · 3,052 cases in index

Docket number

1:19-cv-11746

Nature of suit

835
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal question

Date filed

04/29/2019

Date terminated

07/18/2019

623 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Pfizer, Inc Pharmaceuticals & Biotechnology · 12528 cases
• defendant · Sun Pharma Global Fze · 42 cases

Part of a Larger Litigation Pattern

This is one of 43 Patent - ANDA cases in our index naming Sun Pharma Global FZE — a possible mass-tort or coordinated-litigation cluster.

• Corcept Therapeutics, Inc v. Sun Pharma Global Fze
  District Court, D. New JerseyFiled 07/22/2019
• Pfizer Inc v. Sun Pharma Global Fze
  District Court, D. New JerseyFiled 04/29/2019
• Astellas US LLC v. Sun Pharma Global Fze
  District Court, D. DelawareFiled 10/25/2018
• Sun Pharma Global Fze v. Teva Pharmaceuticals USA, Inc
  District Court, D. DelawareFiled 10/09/2018
• Pharmacyclics LLC v. Sun Pharma Global Fze
  District Court, D. DelawareFiled 10/05/2018
• Forest Laboratories, LLC v. Sun Pharma Global Fze
  District Court, D. DelawareFiled 06/30/2017

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Pfizer Inc v. Sun Pharma Global Fze?

Pfizer Inc v. Sun Pharma Global Fze is a federal patent - anda lawsuit filed on 04/29/2019 in the District Court, D. New Jersey. The case was terminated on 07/18/2019. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. New Jersey, docket number 1:19-cv-11746.

When was the case filed?

Pfizer Inc v. Sun Pharma Global Fze was filed on 04/29/2019. It was terminated on 07/18/2019.